Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 100 for “"polyQ"”.

  1. Model polyQ proteins based on the beta-lactamase BlaP: How non-polyQ regions influence the polyQ length-dependent aggregation process

    … nine disorders are classified as polyglutamine (polyQ) diseases, for which no treatment is yet available. They are all characterized by the pathological expansion of a poly(CAG) sequence, above a specific threshold, within the coding sequence of nine unrelated genes, translated in nine polyQ …

    liege Repository record for Model polyQ proteins based on the beta-lactamase BlaP: How non-polyQ regions influence the polyQ length-dependent aggregation process (opens in a new tab) Restricted access

  2. Early conformational changes control spontaneous polyQ-mediated huntingtin polymerization

    … Parkinson’s disease (PD) and polyglutamine (polyQ) diseases, such as Huntington’s disease (HD). Increasing experimental evidence indicates that conformational changes in disease proteins that precede aggregation are critical for pathogenesis in protein misfolding disorders. Despite the …

    fu-berlin Repository record for Early conformational changes control spontaneous polyQ-mediated huntingtin polymerization (opens in a new tab)

  3. Protein Kinase CK2alpha prime: A Unifying Regulator and Therapeutic Candidate in PolyQ Expansion Disorders and Tauopathies

    … disorders including polyglutamine (PolyQ) expansion disorders such as Huntington’s disease (HD) and Spinocerebellar axtaxia 3 (SCA3), as well as Parkinsons disease (PD), Alzheimer’s disease (AD), Frontotemporal dementia (FTD), and Amyotrophic lateral sclerosis (ALS). Despite this the …

    umn Repository record for Protein Kinase CK2alpha prime: A Unifying Regulator and Therapeutic Candidate in PolyQ Expansion Disorders and Tauopathies (opens in a new tab)

  4. Structure and Thermodynamics of Polyglutamine Peptides and Amyloid Fibrils via Metadynamics and Molecular Dynamics Simulations

    Aggregation of polyglutamine (polyQ)-rich polypeptides in neurons is a marker for nine neurodegenerative diseases. The molecular process responsible for the formation of polyQ fibrils is not well understood and represents a growing area of study. To enable development of treatments that could …

    duquesne Repository record for Structure and Thermodynamics of Polyglutamine Peptides and Amyloid Fibrils via Metadynamics and Molecular Dynamics Simulations (opens in a new tab)

  5. Physiological and pathological role of serine 96 phosphorylation in the regulation of androgen receptor

    … of a CAG tandem repeat encoding a polyglutamine (polyQ) tract in the androgen receptor (AR) gene. SBMA belongs to the family of polyQ diseases, which includes eight other neurological diseases caused by the same mutation in unrelated genes. PolyQ diseases share common features, such as that polyQ …

    trento Repository record for Physiological and pathological role of serine 96 phosphorylation in the regulation of androgen receptor (opens in a new tab)

  6. Nanobodies as tools to investigate the mechanism of aggregation of chimeric proteins made by the insertion of polyglutamine stretches into the beta-lactamase BlaP

    … ten disorders, referred to as polyglutamine (polyQ) diseases and including Huntington's disease and several spinocerebellar ataxias, are associated with ten proteins within which a polyQ tract is expanded above a threshold of typically 35-45 glutamine residues. Such expanded polyQ tracts lead …

    liege Repository record for Nanobodies as tools to investigate the mechanism of aggregation of chimeric proteins made by the insertion of polyglutamine stretches into the beta-lactamase BlaP (opens in a new tab) Restricted access

  7. Structural study of polyglutamine and molecular mechanism of toll-like receptor signaling

    … of a CAG repeats encoding polyglutamine (polyQ) in the first exon of Huntingtin (Htt) gene. In HD patients, polyQ contains 36-183 glutamine residues, whereas normal individuals have a polyQ of only 8-35 residues. To elucidate this threshold phenomenon of polyQ aggregation, fluorescence …

    tamu Repository record for Structural study of polyglutamine and molecular mechanism of toll-like receptor signaling (opens in a new tab)

  8. Aggregationsverhalten des Polyglutaminproteins Ataxin-3 in vitro und in Zellkultur

    Neurodegenerative Polyglutamin (polyQ)-Erkrankungen sind durch neuronalen Zellverlust und die Bildung von intrazellulären Proteinablagerungen (Aggregaten) charakterisiert, deren Rolle nicht exakt geklärt ist. Es wird jedoch davon ausgegangen, daß sie die Pathogenese reflektieren und untrennbar mit …

    lmu-germany Repository record for Aggregationsverhalten des Polyglutaminproteins Ataxin-3 in vitro und in Zellkultur (opens in a new tab)

  9. The Importance Of Protein Context In Spinocerebellar Ataxia Type 3

    … is a member of the family of polyglutamine (polyQ) neurodegenerative disorders that includes Huntington's Disease and several other SCAs. SCA3, the most common dominant ataxia in the world, is caused by polyQ tract expansion in the protein, ataxin-3. How SCA3 occurs and how to treat it remain …

    wayne-thes Repository record for The Importance Of Protein Context In Spinocerebellar Ataxia Type 3 (opens in a new tab)

  10. Investigating Protein Aggregation in Dictyostelium discoideum Biology and Stress Response

    … example being the expanded polyglutamine (polyQ) tracts present in the nine polyQ diseases, including Huntington’s disease. PolyQ aggregation has been studied in a wide array of model organisms in which proteins containing expanded polyQ will form cytotoxic aggregates. However, previous …

    duke Repository record for Investigating Protein Aggregation in Dictyostelium discoideum Biology and Stress Response (opens in a new tab) Embargoed until 2027-01-13

  11. Genomic characterization of human traits associated with polyglutamine disease genes and modifiers

    Background: Polyglutamine (polyQ) diseases, such as Huntington disease (HD) and certain spinocerebellar ataxia, are a group of severe neurodegenerative disorders caused by duplication of the glutamine codon. These conditions currently lack effective treatments, and most therapeutics in development …

    manitoba Repository record for Genomic characterization of human traits associated with polyglutamine disease genes and modifiers (opens in a new tab)

  12. Regulation of the redox homeostasis during polyglutamine misfolding in Huntington’s Disease

    … cellular models of intracellular polyglutamine (polyQ) protein misfolding were established for mechanistic studies.<br/><br/>Various in vitro transient and stable cell expression systems expressing an N-terminal fragment of huntingtin (htt) (httExon 1, httEx1) with/or without a polyQ expansion …

    soton Download PDF for Regulation of the redox homeostasis during polyglutamine misfolding in Huntington’s Disease (opens in a new tab)

  13. DIFFERENT APPROACHES TO UNDERSTAND AND COUNTERACT SPINAL AND BULBAR MUSCOLAR ATROPHY (SBMA).

    … which results in a longer polyglutamine tract (polyQ) at the N-terminus of the protein. PolyQ tract triggers AR protein misfolding and aggregation and leads to nuclear toxicity and cell death. Many efforts have been done to examine in depth disease pathogenesis and to find strategies to …

    milano Repository record for DIFFERENT APPROACHES TO UNDERSTAND AND COUNTERACT SPINAL AND BULBAR MUSCOLAR ATROPHY (SBMA). (opens in a new tab)

  14. TATA binding protein in Alzheimer's Disease

    … diseases, including the heritable polyglutamine (polyQ) disorders such as Huntington disease (HD) and the spinocerebellar ataxias (SCAs). One of this family of disorders, SCA17, is caused by an expansion of a polymorphic polyQ repeat in TATA binding protein (TBP), an essential transcription …

    auckland-ms Repository record for TATA binding protein in Alzheimer's Disease (opens in a new tab)

  15. The role of polyglutamine expansion and protein context in disease-related huntingtin/lipid interactions.

    … is directly caused by an expanded polyglutamine (polyQ) domain in htt, leading to a diverse population of aggregate species, such as oligomers, fibrils, and annular aggregates. Furthermore, the length of this polyQ domain is directly related to onset and severity of disease. The first 17 amino …

    wvu Repository record for The role of polyglutamine expansion and protein context in disease-related huntingtin/lipid interactions. (opens in a new tab)

Page 1 of 5